Filtered By:
Infectious Disease: Hepatitis C
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 11789 results found since Jan 2013.
Clinical performance of the MAGLUMI Anti-HCV (CLIA) Test for detection of hepatitis C virus antibodies
CONCLUSIONS: The performance of the MAGLUMI Anti-HCV (CLIA) Test makes it suited for HCV infection diagnosis.PMID:37419419 | DOI:10.1016/j.jviromet.2023.114770
Source: Journal of Virological Methods - July 7, 2023 Category: Virology Authors: Tinghua Li Hongwei Zhang Zhonggang Fang Jun Yin Wei Rao Source Type: research
Hepatitis C treatment hesitancy among people with heroin dependence in Australia. A prospective cohort study
Med J Aust. 2023 Jul 5. doi: 10.5694/mja2.52013. Online ahead of print.NO ABSTRACTPMID:37408320 | DOI:10.5694/mja2.52013
Source: Med J Aust - July 6, 2023 Category: General Medicine Authors: Chris Tremonti Maree Teesson Christina Marel Katherine Mills Paul S Haber Source Type: research
Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study
CONCLUSION: In the Swiss laboratories considered, more HCV antibody tests were performed each year in the period (2007-2017) before and during the approval of the new hepatitis C drugs. At the same time, the HCV antibody positive rates decreased, both on a per-test as well as a per-person level. This study is the first to describe the evolution of tests performed and of positive rates for HCV antibody in Switzerland at the national level over several years. In order to more accurately guide future measures to achieve the goal of eliminating hepatitis C by 2030, we recommend annual collection and publication of positive rat...
Source: Swiss Medical Weekly - July 6, 2023 Category: General Medicine Authors: Rosario Agosti-Gonzalez Luis Falcato Thomas Grischott Oliver Senn Philip Bruggmann Source Type: research
Hepatitis C treatment hesitancy among people with heroin dependence in Australia. A prospective cohort study
Med J Aust. 2023 Jul 5. doi: 10.5694/mja2.52013. Online ahead of print.NO ABSTRACTPMID:37408320 | DOI:10.5694/mja2.52013
Source: Med J Aust - July 6, 2023 Category: General Medicine Authors: Chris Tremonti Maree Teesson Christina Marel Katherine Mills Paul S Haber Source Type: research
Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study
CONCLUSION: In the Swiss laboratories considered, more HCV antibody tests were performed each year in the period (2007-2017) before and during the approval of the new hepatitis C drugs. At the same time, the HCV antibody positive rates decreased, both on a per-test as well as a per-person level. This study is the first to describe the evolution of tests performed and of positive rates for HCV antibody in Switzerland at the national level over several years. In order to more accurately guide future measures to achieve the goal of eliminating hepatitis C by 2030, we recommend annual collection and publication of positive rat...
Source: Swiss Medical Weekly - July 6, 2023 Category: General Medicine Authors: Rosario Agosti-Gonzalez Luis Falcato Thomas Grischott Oliver Senn Philip Bruggmann Source Type: research
Hepatitis C treatment hesitancy among people with heroin dependence in Australia. A prospective cohort study
Med J Aust. 2023 Jul 5. doi: 10.5694/mja2.52013. Online ahead of print.NO ABSTRACTPMID:37408320 | DOI:10.5694/mja2.52013
Source: Med J Aust - July 6, 2023 Category: General Medicine Authors: Chris Tremonti Maree Teesson Christina Marel Katherine Mills Paul S Haber Source Type: research
Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study
CONCLUSION: In the Swiss laboratories considered, more HCV antibody tests were performed each year in the period (2007-2017) before and during the approval of the new hepatitis C drugs. At the same time, the HCV antibody positive rates decreased, both on a per-test as well as a per-person level. This study is the first to describe the evolution of tests performed and of positive rates for HCV antibody in Switzerland at the national level over several years. In order to more accurately guide future measures to achieve the goal of eliminating hepatitis C by 2030, we recommend annual collection and publication of positive rat...
Source: Swiss Medical Weekly - July 6, 2023 Category: General Medicine Authors: Rosario Agosti-Gonzalez Luis Falcato Thomas Grischott Oliver Senn Philip Bruggmann Source Type: research
Hepatitis C treatment hesitancy among people with heroin dependence in Australia. A prospective cohort study
Med J Aust. 2023 Jul 5. doi: 10.5694/mja2.52013. Online ahead of print.NO ABSTRACTPMID:37408320 | DOI:10.5694/mja2.52013
Source: Med J Aust - July 6, 2023 Category: General Medicine Authors: Chris Tremonti Maree Teesson Christina Marel Katherine Mills Paul S Haber Source Type: research
Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study
CONCLUSION: In the Swiss laboratories considered, more HCV antibody tests were performed each year in the period (2007-2017) before and during the approval of the new hepatitis C drugs. At the same time, the HCV antibody positive rates decreased, both on a per-test as well as a per-person level. This study is the first to describe the evolution of tests performed and of positive rates for HCV antibody in Switzerland at the national level over several years. In order to more accurately guide future measures to achieve the goal of eliminating hepatitis C by 2030, we recommend annual collection and publication of positive rat...
Source: Swiss Medical Weekly - July 6, 2023 Category: General Medicine Authors: Rosario Agosti-Gonzalez Luis Falcato Thomas Grischott Oliver Senn Philip Bruggmann Source Type: research
Can persistent infections with hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human T- lymphotropic virus (HTLV) be eradicated?
AIDS Res Hum Retroviruses. 2023 Jul 6. doi: 10.1089/AID.2022.0116. Online ahead of print.ABSTRACTPersistent viruses (PV) are hard to be eradicated, even using effective medications, and can persist for a long time in humans, sometimes regardless of treatment. Hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human T-cell lymphotropic virus (HTLV) infections, the most common in our era, is still a challenge despite the increased knowledge about their biology. Most of them are highly pathogenic, some causing acute disease or, more often, leading to chronic persistent infections, and so...
Source: Cell Research - July 6, 2023 Category: Cytology Authors: Sandy Vieira Teixeira Gabriela Silva Prates Luiz Augusto M Fonseca Jorge Casseb Source Type: research
